Published in Scand J Gastroenterol on August 01, 2001
Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol (2006) 1.25
Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol (2007) 0.90
HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients. Dig Dis Sci (2007) 0.82
Liver involvement in celiac disease. Minerva Med (2008) 0.81
Human leukocyte antigen DQ2/8 prevalence in non-celiac patients with gastrointestinal diseases. World J Gastroenterol (2013) 0.79
Celiac sprue: a unique autoimmune disorder. Expert Rev Clin Immunol (2009) 0.78
Hepatic and extrahepatic malignancies and primary sclerosing cholangitis. Gut (2003) 0.77
The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood. Gastroenterol Res Pract (2016) 0.75
Problem-based learning: a review of literature on its outcomes and implementation issues. Acad Med (1993) 10.52
Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 9.36
Problem-based learning: is anatomy a casualty? Surgeon (2005) 3.31
Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol (2000) 3.07
Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant (2010) 2.87
A cumulative review of studies on travellers, their experience of illness and the implications of these findings. J Infect (1990) 2.50
The unfolded protein response: an intracellular signalling pathway with many surprising features. Trends Cell Biol (1998) 2.48
Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum (1997) 2.42
Mucosal changes in the gastric stump 20-25 years after partial gastrectomy. Lancet (1977) 2.41
Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis (1998) 2.27
Chief complaint of fatigue: a prospective study. J Fam Pract (1990) 2.25
The "tamponade test" in the management of massive postpartum hemorrhage. Obstet Gynecol (2003) 2.25
Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum (1991) 2.20
Microsatellite identification and characterization in peanut ( A. hypogaea L.). Theor Appl Genet (2003) 2.10
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05
Imported heterosexual HIV infection in London. Lancet (1991) 2.00
Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics (1999) 1.99
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia (2012) 1.98
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene (1997) 1.97
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95
Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens (2000) 1.82
Effects of anal invasive treatment and incontinence on mental health and psychosocial functioning of adolescents with Hirschsprung's disease and low anorectal anomalies. J Pediatr Surg (1998) 1.80
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology (1986) 1.75
Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol (1987) 1.73
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc (1993) 1.72
Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol (2000) 1.67
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66
Y-chromosomal microsatellite mutation rates: differences in mutation rate between and within loci. Hum Mutat (2004) 1.60
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. J Biol Chem (2001) 1.57
Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis (1994) 1.56
Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J Infect Dis (1994) 1.55
New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55
Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54
Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis (2009) 1.54
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Hepatology (1998) 1.53
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53
Germ-line polymorphism of TCR genes and disease susceptibility--fact or hypothesis? Immunol Today (1992) 1.53
Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am J Gastroenterol (1999) 1.52
Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg (1987) 1.51
Respiratory health in a total very low birthweight cohort and their classroom controls. Arch Dis Child (1996) 1.50
Academic stress, power motivation, and decrease in secretion rate of salivary secretory immunoglobulin A. Lancet (1983) 1.49
The obesity gene and colorectal cancer risk: a population study in Northern Italy. Eur J Intern Med (2011) 1.48
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Crit Care Med (2000) 1.47
Portable stove use is associated with lower lung cancer mortality risk in lifetime smoky coal users. Br J Cancer (2008) 1.47
Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med (1992) 1.46
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol (1999) 1.45
A complicated case of exertional heat stroke in a military setting with persistent elevation of creatine phosphokinase. Mil Med (1992) 1.44
Aminoethyl-isothiourea inhibits the increase in plasma endothelin-1 caused by serogroup A streptococci and prolongs survival in rat peritoneal sepsis. Shock (2001) 1.43
Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone. Arch Intern Med (1994) 1.43
T-cell receptor alpha chain germline gene polymorphisms in multiple sclerosis. Neurology (1992) 1.43
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Why patients consult and what happens when they do. BMJ (1991) 1.42
Types of patients in a psychiatric intensive care unit. Aust N Z J Psychiatry (2001) 1.42
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. Eur J Gastroenterol Hepatol (1997) 1.42
Some factors associated with mortality in perforated peptic ulcer: a case-control study. J Gastroenterol Hepatol (1996) 1.42
Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents. Obstet Gynecol (1994) 1.42
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol (2002) 1.40
Unnecessary hospitalisation in a psychiatric rehabilitation unit. BMJ (1992) 1.40
[Natural products can be hazardous to health]. Tidsskr Nor Laegeforen (1992) 1.39
Lipoxins: revelations on resolution. Trends Pharmacol Sci (2001) 1.39
Over the counter treatment for candidiasis. BMJ (1992) 1.39
Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+. Acta Neurol Scand (2007) 1.39
The child who dislikes going to school. Br J Educ Psychol (1967) 1.39
Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells. Leukemia (1992) 1.39
Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Cancer J Sci Am (2006) 1.38
Taking issue with alternative medicine label. Can J Public Health (1998) 1.37
Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol (1995) 1.36
Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol (1992) 1.35
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol (1997) 1.35
Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology (1987) 1.35
The role of surgery in the management of gastric lymphoma. Cancer (1982) 1.31
K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer (1994) 1.31
Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol (1992) 1.31
Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun (1993) 1.31
Selected risk factors in coronary disease. Possible intervention effects. Arch Environ Health (1969) 1.30
The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens (1995) 1.29
Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol (1997) 1.29
Congenital diaphragmatic hernia: a meta-analysis of mortality factors. J Pediatr Surg (2000) 1.28